SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-09-048477
Filing Date
2009-08-10
Accepted
2009-08-10 12:01:24
Documents
9
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a09-18480_110q.htm 10-Q 700013
2 EX-10.72 a09-18480_1ex10d72.htm EX-10.72 232386
3 EX-10.73 a09-18480_1ex10d73.htm EX-10.73 87444
4 EX-10.74 a09-18480_1ex10d74.htm EX-10.74 432120
5 EX-10.75 a09-18480_1ex10d75.htm EX-10.75 26399
6 EX-31.1 a09-18480_1ex31d1.htm EX-31.1 12255
7 EX-31.2 a09-18480_1ex31d2.htm EX-31.2 12324
8 EX-32 a09-18480_1ex32.htm EX-32 8891
9 GRAPHIC g184801ke01i001.jpg GRAPHIC 3925
  Complete submission text file 0001104659-09-048477.txt   1518910
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 09998397
SIC: 2834 Pharmaceutical Preparations